We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Stroli – the shopping trolley reimagined for modern needs. The shopping trolley, often associated with a particular image, is an untapped category ready for innovation. The market is flooded with generic, budget-friendly options that lack charm, with the exception of Rolser, which is pricier and claims the green niche. Stroli steps in as the go-to brand, offering a unique approach, positioning, voice, and eco-friendly credentials. Say goodbye to sore hands and plastic bags – Stroli makes shopping a pleasure with its high-quality, stylish trolley bags designed to enhance your convenience and style
days to go: Extended investment: Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
ioLight makes microscopes that fit in a user's pocket or inside laboratory incubators and display high-resolution images of cells on any mobile phone. The company claims that climate change is driving scientists to the most remote places on earth to look at its impact on the smallest, most fragile organisms. It also stresses that pandemics are driving bioresearch, which relies on monitoring cell growth in incubators. ioLight argues that its products address the aforementioned objectives. The company has sold 400 units to date and aspires to dominate the global microscope market that is worth $9.5 billion and growing at 7.9%. The company has raised £815,000 in equity funding since its launch in 2014 and has featured in two National Geographic videos on Mount Everest and in the BBC Royal Institution Christmas Lectures. It states it will use the investment to accelerate its company revenue and win new opportunities to expand its business.
days to go: Expired investment: £259,586
The Studio enable members to achieve results through sustainable, structured training. The Studio offer a whole range of sessions such as group classes, one-to-one personal training, spinning and yoga.   
days to go: Expired investment: £30,564
Callaly is the UK’s first female care B-Corp that delivers subscription-based organic cotton period products. The company has invented and patented the 'Tampliner', a combination of an organic cotton tampon with a soft mini-liner for built-in leak protection, with a clean insertion and removal, and no hard plastic applicator. It is multi-patented in 30 countries. The company has developed bespoke robotic machinery to automate production at a UK facility. In a £26 billion global femcare market, Callaly claims that its potential tampliner market would constitute 2% to 4% by 2024. The company has received rave reviews from magazines such as Cosmopolitan and Grazia. Callaly plans to begin sales in Europe in the third quarter of 2020 followed by sales in the US and Asia in 2021.
days to go: Expired investment: £1,704,460
Wild & Stone (W&S) is on a mission to make sustainable and stylish items the natural alternatives to commonly used plastics with products like bamboo toothbrushes and reusable steel razors. W&S stresses that its products carry a 30-day no-quibble returns policy, and for every order, it donates to the Marine Conservation Society. W&S argues that it has completed over 100,000 orders, grown its range to include over 85 products, and earned over £850,000 in revenue since its launch. It also points out that it is listed on major marketplaces including, Amazon, NOTHS, Wayfair, eBay, and Etsy. W&S products have been nominated for multiple Amazon choice awards. Its founder, Kathryn Jonas, was shortlisted for the 'Sustainability Entrepreneur of the Year, Southeast region' at the Great British Entrepreneur Awards 2021. The company has featured in publications such as Vogue, The Times, Tatler, Elle, and The Independent. They state they will use the investment to increase its product range and level of inventory.
days to go: Expired investment: £250,460
Revvies Energy (RE) is a nutrition company that argues that its innovative energy strips are a game-changer. The company stresses that 80% of the world's population consumes caffeine every day, which takes at least 45 minutes to an hour to reach its peak. RE states that its energy strips dissolve on the tongue in seconds, providing a faster and efficient performance boost that is less than two calories, vegan and gluten-free. RE has sold over 400,000 packs to date and stocked in more than 400 locations across five countries in entities like Chemist Warehouse Australia, Decathlon Australia, and Amazon marketplaces in the UK, US and Australia. RE was awarded 2021's 'Product Of The Year' in 'Sports Nutrition' by NutraIngredients, Europe's leading nutrition industry title. The company works with athletes across various sports, including RE's Ambassadors Charlotte Purdue (British Marathon Champion 2019 ), top US marathoner, Sara Hall, and dual Australian Olympian, Eloise Wellings. RE states it will use the investment to scale its marketing formula both in the UK and international markets.
days to go: Expired investment: £189,363
First Natural Brands is the owner of Tisserand Aromatherapy, one of the leading self-governing players in UK’s essential oil industry. It offers a variety of affordable organic and quality accredited products which consumers can relish as part of their daily lifestyle. Tisserand Aromatherapy is experiencing a growing interest among media, retail and consumers. Since 2007, the company’s sales have increased from £1.7mn to £6mn, owing to Robin Russell (CEO & Chairman) for bringing Tisserand into the mainstream market with a value for money proposition. Further investment will allow the company to expand its production capacity.
days to go: Expired investment: £325,660
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph